Australia fulfils HIV/AIDS funding commitments to Asia-Pacific:
This article was originally published in Clinica
Australia has committed almost Aus$400m (US$325m) to its Asia-Pacific HIV/AIDS programmes. Last year, Aus$600m was allocated, completing Australia's original Aus$1bn pledge to this region. This year, Indonesia will receive Aus$86m to improve its HIV/AIDS services, as part of a partnership between the two countries. The funds are to be distributed by 2010, through Australia's foreign aid agency AusAID. Special focus will be on Papua New Guinea, where there has been a significant increase in the incidence of HIV/AIDS during the past 10 years (see Clinica No 1246, p 10).
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.